Article info
Public health ethics
Paper
Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
- Correspondence to Dr Chris Degeling, Centre for Values, Ethics and the Law in Medicine, Level 1, Medical Foundation Building, K25, University of Sydney, NSW 2006, Australia; chris.degeling{at}sydney.edu.au
Citation
Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
Publication history
- Received January 28, 2016
- Revised December 12, 2016
- Accepted January 6, 2017
- First published January 31, 2017.
Online issue publication
December 21, 2017
Article Versions
- Previous version (29 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol
- Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea
- Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis
- Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)
- Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
- Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study
- Risk of active tuberculosis in migrants diagnosed with cancer: a retrospective cohort study in British Columbia, Canada
- Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
- Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study
- Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial